A homing beacon for chemotherapy drugs
Credit: Adapted from ACS Central Science 2019, DOI: 10.1021/acscentsci.9b00195 Killing tumor cells while sparing their normal counterparts is a central challenge of cancer chemotherapy. If...
NEWS INDEX
Identifying colorectal cancer subtypes could lead to improved treatment decisions
New study led by a USC Norris Comprehensive Cancer Center researcher could lead to more effective, individualized treatment for patients with metastatic colorectal cancerCredit: Ricardo...
New Cochrane Review assesses evidence on ways to reduce consumption of sugary drinks
Consumption of sugary drinks is considered to be a key driver behind the global obesity epidemic, and is linked with tooth decay, diabetes and heart...
Groundbreaking DNA study launched to discover new connections between genetics & diseases
Study represents largest DNA mapping effort undertaken in US from a single populationCredit: Intermountain Healthcare REYKJAVIK, ICELAND, and SALT LAKE CITY - Intermountain Healthcare and...
Opioid alternative? Taming tetrodotoxin for precise painkilling
Findings in rats suggest that a pufferfish toxin, properly packaged, could offer a safe pain blockCredit: Opioids remain a mainstay of treatment for chronic and...
More men undergo plastic surgery as the daddy-do-over trend rises in popularity
Credit: American Society of Plastic Surgeons Just as women can turn to a suite of procedures, known as the "Mommy Makeover," more men are embracing...
Consortium awarded extra funding to create £9million offshore renewables hub
A national consortium has been awarded additional funding to cement the UK's position as a global leader in offshore renewable energy (ORE) innovation and research....
Disease remission associated with 80% reduction in risk of cardiovascular outcomes
Among traditional risk factors, type II diabetes was significantly associated with both cardiovascular outcomes and pre-clinical cardiovascular disease Annual European Congress of Rheumatology (EULAR 2019)...
Being overweight linked to significantly higher disease severity in psoriatic arthritis
Study emphasizes the need for weight loss interventions alongside symptomatic treatment in patients with psoriatic arthritis Annual European Congress of Rheumatology (EULAR 2019) Madrid, Spain,...
Exposure to inorganic dust increases risk of gout in women by 27%
Results also show that gout is more than twice as likely in alcoholic patients and more than three times as likely in obese patients Annual...
Gout patients suffer in silence with low expectations of treatment
European survey suggests patients re satisfied with their treatment despite inadequate disease management Annual European Congress of Rheumatology (EULAR 2019) Madrid, Spain, 12-15 June 2019...
Study supports glucocorticoid tapering in patients achieving disease control on tocilizumab
Approximately two thirds of patients experience treatment success following glucocorticoid tapering Annual European Congress of Rheumatology (EULAR 2019) Madrid, Spain, 12-15 June 2019 Madrid, Spain,...
Cyclosporine benefits patients through more rapid remission of proteinuria in lupus nephritis
Cyclosporine, azathioprine and mycophenolate mofetil proved to be effective in consolidating and maintaining remission after 10 years follow up Madrid, Spain, 12 June 2019: The...
Low-dose prednisolone significantly improves pain symptoms and function in hand osteoarthritis
HOPE study demonstrates that local inflammation is a suitable target for treatment in patients with debilitating disease Madrid, Spain, 12 June 2019: The results of...
Why fears over smartphone ‘addiction’ are based on flawed evidence
Credit: Lancaster University Most studies into the impact of technology use on psychological wellbeing rely on flawed measures say researchers. Surveys are often used to...
POPULAR NEWS
-
Saying Goodbye to PGY-6: Pediatric Fellowship Realities
-
Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates
-
Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks
-
New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer